Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00118482 · ClinicalTrials.gov registry record · Phase 4
Clinical Trial for the Prevention of Vasovagal Syncope
A Phase 4 study, sponsored by University of Calgary.
- Completed
- Registry status
- Phase 4
- Development phase
- 213
- Enrollment target
NCT00118482: Completed Phase 4 study, sponsored by University of Calgary.
NCT00118482 is a Phase 4 study that has completed, run by University of Calgary. The registered enrollment target is 213 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (59% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00118482, a Phase 4 study, has completed, sponsored by University of Calgary.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 213 participants
- Enrollment target
Study Summary
The main question in the study is whether people taking fludrocortisone are less likely to faint than people taking an inactive pill called a placebo. Fludrocortisone is a drug that stimulates the body to retain salt and water. The investigators know from some studies that it might prevent people from fainting at home and in the community, while they are carrying on with their lives. There is some evidence that salt and water retention help prevent fainting, but no one has a clear idea about whether this is true. This study will try to determine if that is true.
Primary Outcome
This will be measured in terms of number of patients that had at least 1 syncopal spell in the 12 month follow up period.
Interventions
- DRUG fludrocortisone acetate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 213 participants |
| Start Date | 2005-05 |
| Est. Completion | 2011-07 |
| Phase | Phase 4 |
What the finished NCT00118482 record still lists
NCT00118482 is an interventional study that assigns participants to a tested intervention. The registered 213 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (59% lower).
The record links to 0 conditions, and to 1 intervention - of which fludrocortisone acetate is the first listed.
NCT00118482 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00118482 about?
NCT00118482 is a clinical study titled "Clinical Trial for the Prevention of Vasovagal Syncope". The main question in the study is whether people taking fludrocortisone are less likely to faint than people taking an inactive pill called a placebo. Fludrocortisone is a drug that stimulates the body to retain salt and water. The investigators know from some studies that it might prevent people f...
What is the current status of trial NCT00118482?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 213 participants. The study started on 2005-05. Estimated completion is 2011-07.
What interventions are being tested in trial NCT00118482?
The interventions under investigation include: fludrocortisone acetate (DRUG).
Who is sponsoring clinical trial NCT00118482?
This trial is sponsored by University of Calgary, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00118482's enrollment target sits among peer trials
213 396th of 2000 higher than 1,605 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06476886 · 213 participants · NA
Intensive Crisis Intervention
- NCT06544655 · 213 participants · Phase 1
A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors
- NCT07186816 · 213 participants · NA
SUpport From PEeRs to Expand Access Study - Community
- NCT04030507 · 214 participants · NA
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia